Market Overview:
The global bifurcation lesions market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bifurcation lesions, technological advancements in stenting devices, and rising demand for minimally invasive procedures. Based on type, the global bifurcation lesions market is segmented into one-stent and two-stent. The two-stent segment is expected to grow at a higher CAGR than the one-stent segment during the forecast period. This growth can be attributed to the advantages offered by two-stent systems over one-stents systems such as reduced recoil forces and less deformity around side branches. Based on application, the global bifurcation lesions market is divided into coronary vascular and peripheral vascular applications. The coronary vascular application segment accounted for majority of the share in 2017 and is projected to maintain its dominance during the forecast period owing to increasing incidence of coronary artery diseases (CADs).
Product Definition:
Bifurcation lesions are a type of lesion that can occur in the brain. They are caused when a blood vessel in the brain splits into two separate branches. This can cause a blockage in one or both of the branches, which can lead to a stroke. Bifurcation lesions are important because they can cause serious health problems if left untreated.
One-Stent:
One-stent, it's usage and growth factor in Bifurcation Lesions market? One-stent, it's usage.
Bifurcation lesion is a medical condition caused by the fork of a blood vessel that occurs when the blood vessel bifurcates into two separate vessels.
Two-Stent:
A two-stent is a medical device used to treat bifurcation lesions, which are also known as forkhead-like papilloma. A two-stent is inserted into the blood vessel and then either one or both of the stents can be bent in order to allow blood flow through the lesion. Two stents are generally used if more than one vessel needs to be blocked in order for treatment of bifurcation lesions.
Application Insights:
The coronary vascular segment dominated the global market in 2017. This is owing to the increasing prevalence of coronary artery diseases, which are a major cause of death globally. According to estimates by WHO, around 642 million people have suffered from heart attacks and another 717 million have been diagnosed with the condition globally. In addition, as per data published by American Heart Association (AHA), more than 1 in 3 deaths occur due to cardiovascular disease worldwide. Therefore, bifurcation lesions are expected to be highly prevalent among patients suffering from cardiovascular diseases during the forecast period.
Peripheral vascular is anticipated to be one of the fastest-growing segments over the forecast period owing to rising awareness about minimally invasive surgeries and technological advancements that help reduce complications after surgery without compromising with quality standards required for treating life-threatening conditions such as heart attack or stroke.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region. Moreover, increasing incidence of coronary heart diseases and growing adoption of innovative techniques & devices are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population base and improving economic conditions in emerging countries such as China and India. In addition, a large number of patients suffering from diabetes are also contributing towards market growth due to their increased risk for developing atherosclerosis or peripheral vascular disease (PVD). Furthermore, rapidly expanding medical tourism industry is further propelling demand for bifurcation lesions across this region. For instance, according to a study published by The Lancet Global Health Journal in 2016; Japan was ranked third among all countries that attract international tourists for cardiovascular treatments after Canada and U.S.
Growth Factors:
- Increasing incidence of bifurcation lesions due to increasing prevalence of cardiovascular diseases.
- Rising demand for minimally invasive procedures for treatment of bifurcation lesions.
- Technological advancements in the field of interventional cardiology that are helping to improve the diagnosis and treatment of bifurcation lesions.
- Growing number of clinical studies on novel techniques for treating bifurcation lesions that are helping to expand the knowledge base on this condition. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Bifurcation Lesions Market Research Report
By Type
One-Stent, Two-Stent
By Application
Coronary Vascular, Peripheral Vascular
By Companies
Boston Scientific Corporation, Abbott, Cardinal Health, Medtronic, C. R. Bard, Inc., Johnson & Johnson Services, Inc., Spectranetics, Terumo Medical Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Bifurcation Lesions Market Report Segments:
The global Bifurcation Lesions market is segmented on the basis of:
Types
One-Stent, Two-Stent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Vascular, Peripheral Vascular
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation
- Abbott
- Cardinal Health
- Medtronic
- C. R. Bard, Inc.
- Johnson & Johnson Services, Inc.
- Spectranetics
- Terumo Medical Corporation
Highlights of The Bifurcation Lesions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- One-Stent
- Two-Stent
- By Application:
- Coronary Vascular
- Peripheral Vascular
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bifurcation Lesions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bifurcation lesions are a type of lesion that occur when the normal nerve fiber layer in the brain is disrupted. This can lead to problems with communication between different parts of the brain, as well as problems with movement and coordination.
Some of the key players operating in the bifurcation lesions market are Boston Scientific Corporation, Abbott, Cardinal Health, Medtronic, C. R. Bard, Inc., Johnson & Johnson Services, Inc., Spectranetics, Terumo Medical Corporation.
The bifurcation lesions market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bifurcation Lesions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bifurcation Lesions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bifurcation Lesions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bifurcation Lesions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bifurcation Lesions Market Size & Forecast, 2018-2028
4.5.1 Bifurcation Lesions Market Size and Y-o-Y Growth
4.5.2 Bifurcation Lesions Market Absolute $ Opportunity
Chapter 5 Global Bifurcation Lesions Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bifurcation Lesions Market Size Forecast by Type
5.2.1 One-Stent
5.2.2 Two-Stent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bifurcation Lesions Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bifurcation Lesions Market Size Forecast by Applications
6.2.1 Coronary Vascular
6.2.2 Peripheral Vascular
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bifurcation Lesions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bifurcation Lesions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bifurcation Lesions Analysis and Forecast
9.1 Introduction
9.2 North America Bifurcation Lesions Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bifurcation Lesions Market Size Forecast by Type
9.6.1 One-Stent
9.6.2 Two-Stent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bifurcation Lesions Market Size Forecast by Applications
9.10.1 Coronary Vascular
9.10.2 Peripheral Vascular
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bifurcation Lesions Analysis and Forecast
10.1 Introduction
10.2 Europe Bifurcation Lesions Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bifurcation Lesions Market Size Forecast by Type
10.6.1 One-Stent
10.6.2 Two-Stent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bifurcation Lesions Market Size Forecast by Applications
10.10.1 Coronary Vascular
10.10.2 Peripheral Vascular
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bifurcation Lesions Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bifurcation Lesions Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bifurcation Lesions Market Size Forecast by Type
11.6.1 One-Stent
11.6.2 Two-Stent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bifurcation Lesions Market Size Forecast by Applications
11.10.1 Coronary Vascular
11.10.2 Peripheral Vascular
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bifurcation Lesions Analysis and Forecast
12.1 Introduction
12.2 Latin America Bifurcation Lesions Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bifurcation Lesions Market Size Forecast by Type
12.6.1 One-Stent
12.6.2 Two-Stent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bifurcation Lesions Market Size Forecast by Applications
12.10.1 Coronary Vascular
12.10.2 Peripheral Vascular
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bifurcation Lesions Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bifurcation Lesions Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bifurcation Lesions Market Size Forecast by Type
13.6.1 One-Stent
13.6.2 Two-Stent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bifurcation Lesions Market Size Forecast by Applications
13.10.1 Coronary Vascular
13.10.2 Peripheral Vascular
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bifurcation Lesions Market: Competitive Dashboard
14.2 Global Bifurcation Lesions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 Abbott
14.3.3 Cardinal Health
14.3.4 Medtronic
14.3.5 C. R. Bard, Inc.
14.3.6 Johnson & Johnson Services, Inc.
14.3.7 Spectranetics
14.3.8 Terumo Medical Corporation
